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Inverse planned intensity modulated radiation therapy IMRT has become commonplace in treat-
ment centers across the world. Due to the implications of beam complexity on treatment planning,
delivery, and quality assurance, several methods have been proposed to reduce the complexity.
These methods include beamlet intensity restrictions, smoothing procedures, and direct aperture
optimization. Many of these methods typically sacrifice target coverage and/or normal tissue spar-
ing in return for increased beam smoothness and delivery efficiency. In the present work, we
penalize beam modulation in the inverse planning cost function to reduce beam complexity and
increase delivery efficiency, while maintaining dosimetric quality. Three modulation penalties were
tested: two that penalized deviation from Savitzky-Golay filtered versions of the optimized beams,
and one that penalized the plan intensity map variation a measure of overall beam modulation.
The modulation penalties were applied at varying weights in a weighted sum objective or cost
function to investigate their ability to reduce beam complexity while preserving IMRT plan quality.
The behavior of the penalties was characterized on a CT phantom, and then clinical optimization
comparisons were performed in the brain, prostate, and head/neck. Comparisons were made be-
tween i plans with a baseline cost function ii plans with a baseline cost function employing
maximum beamlet intensity limits, and iii plans with each of the modulation penalties added to
the baseline cost function. Plan analysis was based upon dose-volume histograms, relevant dose
metrics, beam modulation, and monitor units required for step and shoot delivery. Each of the
techniques yielded improvements over a baseline cost function in terms of MU reduction. In most
cases, this was achieved with minimal change to the plan DVHs and metrics. In all cases, an
acceptable plan was reached with each of the methods while reducing MU substantially. Each
individual method has merit as a tool for reducing IMRT beam complexity and could be easily
applied in the clinic to improve overall inverse plan quality. However, the penalty based upon the
plan intensity map variation consistently produced the most delivery-efficient plans with the fewest
computations. © 2007 American Association of Physicists in Medicine.
DOI: 10.1118/1.2409749
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The evolution of intensity modulated radiation therapy
IMRT into a common radiotherapy treatment modality has
brought into focus not only its potential advantages, such as
improved target conformality, easier planning of simulta-
neous boost treatments, and reductions in overall normal tis-
sue toxicity, but also potential disadvantages. With the inher-
ent flexibility in planning afforded by the complex inverse
planning optimization process comes certain limitations to
efficient IMRT planning and delivery. The inverse planning
process itself is subject to noise and artifacts that may yield
undesirable high-intensity peaks and small beamlet-to-
507 Med. Phys. 34 „2…, February 2007 0094-2405/2007/34„beamlet fluctuations across a given IMRT field. These arti-
facts can complicate the IMRT planning process and prevent
accurate and efficient deliveries.
Previous efforts to reduce IMRT beam complexity include
the application of beamlet restrictions, the use of beam
smoothing procedures, and the direct optimization of multi-
leaf collimator segments. The use of beamlet restrictions,
such as applying maximum intensity limits to beamlets dur-
ing optimization, can reduce modulation and increase deliv-
ery efficiency as long as the limits are not so strict as to
interfere with the dosimetric plan objectives.1 Applying in-
tensity limits allows the cost function to work independently
of any outside criteria, although intensity limits may only
partly reduce the consequences of the beam complexity
5072…/507/14/$23.00 © 2007 Am. Assoc. Phys. Med.
508 Matuszak, Larsen, and Fraass: IMRT beam complexity reduction using modulation penalties 508problem by removing large intensity spikes. The large in-
creases in the MU requirements for IMRT plans compared
to a conventional conformal plan can be a consequence of
high-intensity peaks within the optimized beams. The use of
maximum intensity limits can remove these peaks and be
beneficial for many cases, but it does not prevent smaller
fluctuations in modulation between neighboring beamlets
that can also increase MU. In these cases, the discretization
of intensity levels also done to varying degrees in leaf se-
quencing procedures during optimization may be useful, as-
suming that an acceptable plan can be found in the reduced
solution space.2,3
Smoothing procedures can be applied either inside or out-
side the optimization loop. Smoothing IMRT beams outside
the optimization process may either produce limited results
or require reoptimization due to the plan degradation that
occurs during postoptimization smoothing.4–6 Inside the op-
timization loop, smoothing can be done by i including
smoothness criteria inside the objective function or ii
smoothing beams after each cycle or iteration.7 The latter
method is easier to implement, but it suffers from the same
difficulty as applying interventions postoptimization: when
any procedure is applied outside the cost function, the impact
of that procedure on the cost function cannot be weighed
according to the dosimetric consequences. Procedures in this
category include smoothing after each iteration, applying
maximum beamlet intensity limits, and discretizing the num-
ber of allowable beamlet intensity levels. These methods
generally cannot distinguish between desirable and undesir-
able gradients and are likely to degrade plans in areas where
steep gradients are necessary.5,7 Each of the above methods,
while superior to methods that are applied outside the opti-
mization loop, may still interfere with the ability of the op-
timization system to meet the inverse planning objectives. In
previous studies, this has resulted in inferior target
coverage.7
Implemented carefully, methods that penalize modulation
as a part of the cost function can effectively improve delivery
efficiency, while taking into account the dosimetric tradeoffs
to be made with IMRT plan objectives. Spirou et al. have
presented a comparison of smoothing, using a Savitzky-
Golay filter along the direction of the MLC leaf travel, inside
and outside the cost function. They found that smoothing
inside the cost function was superior in terms of producing
sharper dose gradients, better dose homogeneity, and better
critical organ sparing, especially for more complex cases.7
However, again, care must be taken to design the objective
function in such a way that the smoothing process or modu-
lation penalty does not dominate the solution and interfere
with normal tissue dose limits or target coverage.8
Another approach to reduce beam modulation is to di-
rectly optimize the shapes and weights of the actual MLC
segments that will be used in the delivery of the IMRT
plan.9–14 This approach removes the need for leaf sequencing
and eliminates errors introduced by sequencing approxima-
tions. Although there has not been a comprehensive work
comparing direct aperture optimization DAO with fluence
Medical Physics, Vol. 34, No. 2, February 2007map optimization FMO, several studies point to the conclu-
sion that DAO and FMO perform similarly in terms of dosi-
metric quality and MU in simple cases, such as breast,9 but
FMO may still produce better dosimetric results in normal
tissues for more complicated cases, such as head and
neck.10,11 The required MU and segments can be substan-
tially less for DAO in these cases, justifying a slight loss in
clinical quality. It should be noted that improved leaf se-
quencing algorithms have been shown to close the delivery
efficiency gap between DAO and FMO.15
As we further our knowledge of IMRT, it has become
clear that the value of an IMRT plan should not be judged
solely on the resulting DVHs and dose metrics, but also on
the efficiency of delivery and other potential problems asso-
ciated with the plan, such as increased time and effort needed
for quality assurance. The work presented here examines
several IMRT beam modulation penalties that can be applied
as part of the inverse planning cost function, to determine
which is best-suited to preserve plan quality regarding i
target and normal tissue DVHs and dose metrics and ii
reduced modulation and improved delivery efficiency.
II. METHODS
To promote beam smoothing as part of the inverse plan-
ning objective function, three beam modulation penalties
were implemented into our in-house treatment planning and
optimization system UMPlan/UMOpt.16–22 UMOpt is a
versatile software package designed for 3-D beamlet-based
inverse IMRT optimization that can make use of specialized
cost function components, or “costlets.” In this work, we
study three new costlets that aim to reduce IMRT beam com-
plexity when included in an inverse plan objective function.
The three costlets do the following: i minimize deviation
from a 1-D Savitzky-Golay filtered beam where filtering is
done only in the direction of the MLC travel, ii minimize
deviation from a 2-D Savitzky-Golay filtered beam, or iii
minimize a measure of the total plan modulation called the
quadratic plan intensity map variation PIMVq.1 In order to
perform an investigation of these costlets, each was used in
the optimization of an IMRT plan for a CT phantom. After
testing in the phantom, nine clinical cases three each for
brain, prostate, and head/neck were optimized using each of
the three modulation costlets added to the baseline cost
function and compared to the plan generated using just the
baseline cost function. Comparison was also made to plans
employing the same baseline cost function with maximum
beamlet intensity limits. We briefly describe each of these
methods below.
A. Standard IMRT with a baseline cost function
The standard IMRT optimization plans the baseline for
the comparisons were simply obtained by optimization of
the beamlet intensities according to the minimization of a
baseline cost function, without any beam modulation penal-
ties. No restrictions were placed on the allowed values of the
beamlet intensities.
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IMRT optimization was performed with the baseline cost
function as in Sec. II A, but the maximum beamlet intensity
in the plan was limited to a predetermined value proportional
to the prescription dose divided by the number of beams.1
This method, discussed in more detail in previous work, was
shown to be a simple and effective way to reduce plan MU
while reaching all of the plan objectives.1 We have included
it in this analysis to determine whether the more advanced
methods of reducing modulation shown below are more ad-
vantageous.
C. Beam modulation penalty based on 1-D
Savitzky-Golay filtering „SG1D…
The same baseline cost function was used as in the previ-
ous two methods, but a modulation penalty based on the one
used successfully by Spirou et al.7 was included as a part of
the cost function. In addition to the costs calculated for the
targets and normal tissues, the following costlet was added
into the objective function:
C = w
i=0
B
bi − si2. 1
Here, w is the weight assigned to the smoothing importance,
B is the number of beamlets in the plan, bi is the value of the
ith beamlet, and si is the value of the ith beamlet after the
smoothing operation. The smoothed value, si, is calculated
using a Savitzky-Golay filter.23 This filter performs a least-
squares fit to the elements within a smoothing window to a
given degree polynomial a second order polynomial is used
here. The smoothing window is a five row vector of beam-
lets centered at bi in the direction of the MLC leaf motion.
D. Beam modulation penalty based on 2-D
Savitzky-Golay filtering „SG2D…
Optimization was performed as in Sec. II C, but the
smoothed beamlet values, si, were calculated using a 55
beamlet grid centered at bi as the smoothing window. This
was done to promote modulation reduction in all directions,
not just in the direction parallel to MLC travel.
E. Beam modulation penalty based on PIMVq
Optimization was performed as in the previous two meth-
ods, but the beam modulation penalty was based upon a dif-
ferent measure of beam modulation. In addition to the cost-
lets included in the baseline cost function, the following
costlet was added to the total objective function calculation:
C = w PIMVq. 2
Here, w is the weight assigned to the smoothing importance
and PIMVq is a quadratic version of the plan intensity map
variation PIMV, described previously.1 The PIMV provides
a measure of the beam modulation across an intensity modu-
lated beam, and PIMVq was defined to simplify the calcula-
Medical Physics, Vol. 34, No. 2, February 2007tion of the gradient during the optimization procedure. The
latter quantity is defined as
PIMVq = 
n=1
Nb 
j=1
J−1

k=1
K−1 bjk − bj,k+12 + bjk − bj+1,k2
+
1
2
bjk − bj+1,k+12 +
1
2
bjk − bj+1,k−12	 , 3
where Nb is the number of beams in a plan, J is the maxi-
mum number of beamlets in the direction parallel to the mo-
tion of the multileaf collimator MLC, K is the maximum
number of beamlets in the direction perpendicular to the mo-
tion of the MLC, and bjk is the intensity of the beamlet at the
j ,k grid position. The four terms in Eq. 3 allow all dif-
ferences between each neighboring beamlet, including the
diagonal beamlets, to be taken into account.
The weights used in Eqs. 1 and 2 were varied to dem-
onstrate the potential impact of the beam modulation penal-
ties on the optimal intensity modulated beams as the impor-
tance of smoothness was increased.
F. Treatment planning and analysis
As mentioned previously, each of the modulation penal-
ties was validated on a CT phantom and then tested on nine
clinical cases—three each for brain, prostate, and head/neck.
These plans were then compared to plans employing a base-
line cost function or maximum intensity limits. One optimi-
zation run was done for the baseline cost function and then
several optimization trials were run for each of the other four
techniques to characterize plans at a variety of maximum
intensity limits and with a range of weights applied to the
modulation penalties. The geometry and beam arrangement
for the simple CT phantom are shown in Fig. 1, and the high
priority planning objectives for the phantom and clinical
cases are shown in Table I. In addition, each plan included a
lower priority objective of minimizing overall dose to all of
the normal structures and uninvolved normal tissues. These
FIG. 1. Illustration of the CT phantom geometry and beam placement. The
PTV is the center sphere, “Small” is the off-center sphere, and “Cylinder” is
the cylindrical structure. The external contours were not used in the cost
function to save calculation time. Note: some figures may appear in color
only in the electronic version.objectives were given a low weight so as to not interfere with
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cal plan objectives were chosen based on in-house IMRT
protocols.
Brain cases were optimized with four or five beams origi-
nally placed by a dosimetrist, prostate plans were optimized
with nine equally spaced axial beams, and head/neck cases
were optimized using seven equally spaced axial beams. All
cases were planned for a 6 MV linear accelerator Varian
TABLE I. Inverse planning objectives for the CT pha
CT phantom inv
Structure
PTV
PTV+1 cm
Small
Small+1 cm
Cylinder
Brain invers
Structure
PTV1
PTV2
Optic nerves
Optic chiasm
Brainstem
Prostate inver
Structure
Prostate+3 mm
Rectum
Bladder
Femora
Penile bulb
Uninvolved tissue
Head/neck inve
Structure
PTV
Nodal boost PTV
High risk nodal PTV
Low risk nodal PTV
Spinal cord
Spinal cord+5 mm
Brainstem
Contralateral parotid
Ipsilateral parotid
Mandible
Submandibulars
Oral cavityMedical Systems, 21EX with 120 leaf MLC 0.5 and 1.0 cm
Medical Physics, Vol. 34, No. 2, February 2007leaf widths. Dose calculations for the inverse planning sys-
tem were performed by a convolution/superposition algo-
rithm derived from the work of Mackie et al.24 All cases
were optimized using a quasi-Newton-based search strategy.
Plans were initialized with several different starting intensity
patterns to ensure that the optimized plans did not represent
local minima of the cost function.
After optimization, leaf sequencing for static MLC
and clinical cases.
plan objectives
Objectives
60 Gy; 66 Gy
50 Gy; 66 Gy; 20%60 Gy
15%25 Gy
66 Gy; Mean20 Gy
70 Gy
objectives
Objective
Gy min 95%, max 105%, and 1% volume up to
110%
Gy min 95%, max 105% of PTV1 with PTV1
coverage priority
60 Gy
60 Gy
65 Gy
an objectives
Objectives
n=75.85 Gy±3%; 0.5 cc down to 93%; 0.5 cc
up to 115%
15%80 Gy; 25%75 Gy; 35%70 Gy;
50%65 Gy
15%80 Gy; 25%75 Gy; 35%70 Gy;
50%65 Gy
Mean50 Gy;10%52 Gy
Mean52.5 Gy; 15%70 Gy
100% Rx Dose; Mean52.5 Gy; 15%70 Gy
lan objectives
Objectives
70 Gy±5%
70 Gy±5%
66 Gy±5%
60 Gy±5%
45 Gy
50 Gy
54 Gy
Mean26 Gy
ean26 Gy if possible, otherwise minimize
70 Gy
Minimize dose
70 Gyntom
erse
e plan
66
60
se pl
Mea


Max
rse p
MSMLC delivery was performed with an in-house-developed
tensi
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al.25 Delivery sequences allow up to 250 segments per beam,
with the goal of achieving a correspondence between
planned and delivered intensities of 1%.
Optimization results for each of the different techniques
were compared using dose metrics, DVHs, field modulation
and complexity, and efficiency of SMLC delivery. The re-
sults from the modulation penalty validation in the CT phan-
tom are presented first and then all methods are compared in
the three clinical sites. Our analysis of these results at-
tempted to determine which method produced the highest
quality IMRT plans, taking into account the target and nor-
mal tissue planning objectives and other important factors
such as overall beam complexity and delivery efficiency.
III. RESULTS
A. Modulation penalties in the phantom
The CT phantom case Fig. 1 was optimized with the
baseline objective function described in Table I, and then
optimization was performed including each of the modula-
tion penalties with a number of different weights. Figure 2a
shows the net cost objective function value less the modu-
lation penalty and relative SMLC MU as a function of in-
creasing modulation penalty weight this is a qualitative
weight for plotting purposes, not the actual weight used in
the optimization, as that varied for each case and method
when including each of the three modulation penalties in the
cost function. The results from the baseline cost function are
also shown. With increasing modulation penalty weights, we
observe large decreases in MU along with a rising trend in
the net cost. The net cost increases because, as the modula-
tion penalty increases, the plan deviates further from the
baseline optimized plan. To minimize the modulation pen-
alty, tradeoffs are usually made with the lower priority ob-
jective of minimizing total dose to the normal tissues. This is
indicated by the slowly increasing net cost at the lower pen-
alty weights. As the weight increases further, we observe a
steeper increase in the net cost as the modulation penalties
begin to dominate the optimization and various high priority
FIG. 2. Optimization results for the CT phantom when including modulati
function of increasing modulation penalty weight in a, and relative plan inobjectives are violated. In a clinical case, one would likely
Medical Physics, Vol. 34, No. 2, February 2007not choose a smoothing penalty weight that interfered with
the high priority objectives. The extent to which the modu-
lation penalty would be allowed to trade off with lower pri-
ority objectives would have to take into account the increase
in normal tissue dose versus the reduction in MU and beam
complexity.
To examine the relationship between the monitor units
and beam modulation, we also calculated the total plan in-
tensity map variation equal to a nonquadratic version of Eq.
3, which is a measure of plan modulation in Fig. 2b. The
relative plan intensity map variation varied from 0.20 to
0.80, indicating the possibility for large reductions in beam
complexity with the use of the modulation penalties. We also
saw that the use of the PIMVq penalty produced plans that
had the lowest amount of modulation, followed by use of the
SG2D penalty, and then the SG1D penalty. In addition, be-
cause the SG1D plans promote smoothing only in the direc-
tion of the MLC travel, we saw only a slight increase in the
MU as compared to the SG2D plans. This means that the
SG1D plans retained the most modulation while still seeing a
reduction in MU. At higher SG1D penalties, the beams
started to deviate from the trend of decreasing modulation
and MU. Therefore, this penalty may be less useful at high
weights where nonconformance to the filtered beams is
highly penalized.
As shown in Fig. 2, the penalty weights were chosen so
that the optimized plans would have almost identical objec-
tive function values. This required several iterations of
choosing the modulation penalty weights, but it allowed for
fair plan comparisons. Dose-volume histograms and the in-
tensity modulated beams for the cases optimized at relatively
low penalty weights a and b and high penalty weights c
and d are shown in Fig. 3. For the lower penalty weights,
which correspond to a weight of 3 in Fig. 2, the normal
tissue DVHs were nearly identical to those in the baseline
plan. The target coverage is not compromised, but does be-
come more homogeneous as the fields become smoother. In
Fig. 3b, large differences between the beam intensity pat-
terns for each of the modulation penalized plans and the
nalties in the cost function. Net cost and relative SMLC are shown as a
ty map variation and net cost are shown in b.on pebaseline plan can be seen. For the SG1D penalty, the optimal
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dicular to the MLC motion. This happens because the filter-
ing is done only in the direction of leaf travel. As Spirou et
al. suggest, we chose a five beamlet smoothing window,
since using a larger smoothing window resulted in an exag-
geration of this step function observation, with each row of
beamlets having an almost identical weight. Conversely, we
found that the use of a smaller window resulted in minimal
smoothing and minimal reduction in MU as compared to the
baseline plan. The use of the SG2D penalty produced more
highly smoothed versions of the original plan with large re-
ductions in i the amount of the modulation, ii the number
of high intensity beamlets, and iii the size of beamlet-to-
beamlet variations. In the plan optimized with the PIMVq
penalty, the fields were relatively uniform, with the second
beam delivering the majority of the intensity. In these beams,
the modulation was high only in areas near the overlap of the
PTV and the “Small” structure.
In Figs. 3c and 3d, the DVHs and beams for plans
optimized at higher modulation penalties corresponding to a
weight of 7 in Fig. 2 are shown. In these optimization trials,
we saw an increase in the normal tissue dose while the target
coverage remained fairly consistent due to the design of the
cost function. However, there were slight violations of the
minimum dose objective in the PTV expansion and the dose-
volume objective in the “Small” structure. As a result of the
increasing modulation penalty weight, the beam complexity
was further decreased compared to Fig. 3b, although the
peak locations in the SG1D beams were inconsistent with the
original plan. The SG2D beams were smoothly varying and
Medical Physics, Vol. 34, No. 2, February 2007the intensity was well distributed throughout the three
beams. The PIMVq beams were similar to the beams pro-
duced at the lower penalty weight, although i they were
much more uniform, ii beam 2 was slightly more intense,
and iii the modulation was further reduced. Looking at the
large differences in the beam intensity patterns, it appears
that the phantom case has a large solution space, i.e., there
are many different beam combinations that lead to very simi-
lar DVH results.
For this CT phantom example, the PIMVq penalty
achieved the same total objective function values with lower
degrees of beam complexity and MU than the SG penalties.
However, tradeoffs are still being made within the dose ob-
jectives, and each of the modulation penalties causes slightly
different tradeoffs to be made in the cost function. Thus,
each of the penalties may have merit in different geometries
and in situations where planners may have different tradeoff
preferences. We hypothesize that the SG1D and SG2D pen-
alties will be useful in cases that require high intensity gra-
dients across a field, and that the PIMVq penalty will be most
applicable because it generally provides the same objective
value for the least amount of beam complexity. These ideas
will recur in the discussion of the results from the brain,
prostate, and head/neck trials.
B. Clinical studies
Nine clinical cases were optimized using each of the three
modulation penalties in the objective function at varying
FIG. 3. a Optimized DVHs and b intensity modu-
lated beams when using a relatively low modulation
penalty weight corresponds to a weight of 3 in Fig. 2
in the phantom case. c Optimized DVHs and d in-
tensity modulated beams when using a relatively higher
modulation penalty weight corresponds to a weight of
7 in Fig. 2 in the same case. Results using the baseline
cost function are shown for comparison.weights. The results were compared to plans using the base-
e pla
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intensity limits. The inclusion of the modulation penalties at
reasonable weights did not compromise the clinical planning
objectives and generally resulted in smoother, less complex
intensity patterns that could be delivered with significant re-
ductions in monitor units compared to the baseline IMRT
plans. This gain in delivery efficiency was sometimes at the
expense of increased dose to the normal tissues. Therefore,
in addition to the results presenting the maximum MU reduc-
tions while still meeting the clinical objectives, we have in-
cluded the maximum MU reduction while maintaining all
normal tissue mean doses achieved with the baseline cost
function. This was done by adding mean dose costlets along
with the modulation penalties to the baseline cost function at
the mean dose levels achieved by the baseline plan optimi-
zation. These results will be discussed for each individual
treatment site.
1. Brain
In the three brain cases tested, each beam complexity re-
duction technique produced plans that met the high priority
dose objectives and could be delivered with a significant MU
reduction compared to the baseline IMRT plan. Figure 4
FIG. 4. Plots illustrating relative MU versus net cost tradeoffs in the brain c
function and maximum intensity limits. All values are relative to the baselinMedical Physics, Vol. 34, No. 2, February 2007shows all of the optimization runs plotted as relative MU
versus net cost. In each plan shown, all of the high priority
objectives in Table I are met. The increase in delivery effi-
ciency seen in the brain is usually gained as a result of a
tradeoff between the modulation penalty or maximum
beamlet intensity and the low-priority objective of minimiz-
ing overall dose to the normal tissues. This can be seen in
Fig. 5a, which shows, for brain3, optimized DVHs with the
baseline cost function, with maximum intensity limits, and
with each of the modulation penalties applied. The plans
shown are at moderate modulation penalty weights and are
very similar in net cost. The intensity modulated beams from
each of the techniques are shown in Fig. 5b. A reduction in
overall beam modulation from the baseline cost function to
the other techniques can be seen, and the MU reductions are
shown in parentheses. The same general trend in relative MU
was observed in the other brain cases with the PIMVq modu-
lation penalty, consistently producing the largest reduction in
MU at similar objective function values, followed by maxi-
mum intensity limits, the SG2D penalty, and then the SG1D
penalty Fig. 4. The maximum possible MU reductions for
each method compared to the baseline plan are shown in
Table II for each of the brain cases. The maximum possible
when using each of the modulation penalties compared to the baseline cost
n.
FIG. 5. a Brain3 DVHs shown op-
timized with each of the different
techniques for reducing modulation
and b corresponding Brain3 beams
optimized with each of the beam
modulation reduction methods.
SMLC reductions are in parentheses.ases
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sible while still meeting all of the high priority clinical plan-
ning objectives in Table I. In practice, these plans may not be
acceptable to the physician because there can be significant
mean dose increases in the normal tissues. Therefore, we
have also included the more modest maximum MU reduc-
tions possible when maintaining the mean normal tissue
doses from the baseline plans. Realistic MU reductions for
clinical practice may lie between these two values and would
be based on the individual plan and physician tradeoff pref-
erences. The smaller decreases in MU for brain2 may be
explained by a lack of modulation in the fields for the origi-
nal cost function, as the plan was relatively simple without
involvement of the optic nerves. The SG penalties may not
have resulted in a large MU reduction because the original
beams already closely resembled the filtered beam. Since the
PIMVq plans were penalized based on the total modulation,
they have the greatest MU decrease, along with the relatively
flat maximum intensity limited plans.
2. Prostate
In the three prostate cases tested, each technique produced
plans that met the high priority dose volume objectives and
demonstrated significant reductions in MU. Relative MU are
plotted versus net cost in Fig. 6 for all of the prostate cases
tested. In prostate1, the MU reductions were largest for plans
using maximum intensity limits or the PIMVq penalty. In
prostate2 and prostate3, the PIMVq plans consistently re-
quired the fewest MU at a similar net cost and demonstrated
TABLE II. Maximum MU reductions possible in the b
high priority plan objectives and ii maintaining me
Brain1
Optimization technique i only i and i
Maximum intensity limits 49.0% 9.4%
SG1D filter penalty 35.8% 3.9%
SG2D filter penalty 49.2% 12.7%
PIMVq penalty 56.7% 16.4%
FIG. 6. Plots illustrating relative MU versus net cost tradeoffs in the prostat
function and maximum intensity limits. All values are relative to the baseline pla
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weights compared to the Savitzky-Golay filter-based modu-
lation penalties. All techniques, however, produced accept-
able plans with large MU reductions. The main tradeoff for
improved delivery efficiency was, again, a slight increase in
overall dose to the normal tissues. This can be seen in the
prostate1 DVH comparisons for all methods in Fig. 7a. All
plans shown met the objectives in Table I and have similar
values of net cost. The DVHs for the plans with modulation
penalties are all very similar, while the maximum intensity
limited plan had the highest dose to the rectum along with
reduced dose to the femora. This demonstrates the availabil-
ity of plan tradeoffs possible to achieve the same objective
function value. Four of the nine beams from each of the
optimized plans are shown in Fig. 7b. Here we see that the
maximum intensity limited beams look very different from
the rest of the beams, supporting the large shape differences
that were observed in the plan DVHs. The reduction in over-
all beam complexity for the non-baseline plans is apparent in
the intensity maps, and the MU percent reductions compared
to the baseline cost function are shown in parentheses. To
further illustrate the tradeoff between beam smoothing and
normal tissue mean dose, Fig. 8 shows mean doses plotted as
a function of relative SMLC MU for each of the normal
structures in each prostate case. The PTV mean and mini-
mum doses are also shown. This demonstrates that the mini-
mum dose to the target stays constant as the modulation pen-
alties increase. However, the mean doses to the normal
tissues increase as the MU decrease. This is more prominent
using each optimization technique while i meeting
rmal tissue doses from the baseline plan.
Brain2 Brain3
i only i and ii i only i and ii
27.3% 2.5% 31.1% 4.7%
10.1% 0.0% 22.4% 13.5%
18.1% 3.6% 27.5% 12.9%
25.8% 12.8% 39.1% 13.1%
s when using each of the modulation penalties compared to a baseline costrain
an no
ie case
n.
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and bladder. The plots for prostate1 and prostate2 also show
the inconsistent behavior of the SG penalties at higher
weights.
Table III shows the maximum MU reductions possible
when applying each of the modulation reduction methods.
The first column shows the maximum MU reduction possible
while still meeting all of the high priority plan objectives, but
allowing for tradeoffs with the lower priority objective of
FIG. 8. Doses in each prostate case plotted as a function of SMLC MU when
dose are shown along with normal tissue mean doses.
Medical Physics, Vol. 34, No. 2, February 2007minimizing overall dose to the normal tissues. The second
column shows the MU reduction possible while meeting the
high priority objectives and maintaining the mean normal
tissue doses achieved in the baseline plan. We have included
the DVHs for the prostate1 plans that correspond to the latter
in Fig. 9. Here, we see a slight change in the shape of the
rectum DVH, but the rest of the normal tissue and target
DVHs are unchanged. Thus, MU reductions occur on the
order of 18.9%–26.6% when applying the PIMVq penalty in
FIG. 7. a Prostate1 DVHs shown
optimized with each of the beam
modulation reduction methods and
b corresponding Prostate1 beams
2, 4, 6, and 8 out of 9 optimized with
each of the beam modulation reduc-
tion methods. SMLC reductions are
in parentheses.
each of the optimization techniques. Trends in the PTVminimum and meanusing
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pared to the baseline plans. These MU reductions are actu-
ally quite similar to the reductions seen in what appear to be
“worse” plans in Fig. 7. This demonstrates one of the disad-
vantages of using a weighted sum cost function and shows
why one must be explicit in the definition of the objectives.
If dose to the normal tissues is weakly penalized, as it usu-
ally is in a weighed sum cost function so as to not interfere
with the more important objectives, the plan will have little
incentive to reduce that dose. In Fig. 9, where we include
costlets that limit the normal tissue mean doses to those we
know were already achievable in the baseline plan, those
limits were able to be adhered to while still reducing the
MU. We would also like to note that the considerable MU
decreases observed in the prostate compared to the brain are
likely a function of both baseline plan complexity and the
reduced beamlet size 0.5 cm by 0.5 cm as compared to
1 cm by 1 cm used in the prostate plans.
3. Head/neck
The head/neck body site included the highest number of
targets and normal structures in the cost function. The cases
TABLE III. Maximum MU reductions possible in th
meeting high priority plan objectives and ii mainta
Prostate1
Optimization technique i only i and i
Maximum intensity limits 62.6% 20.9%
SG1D filter penalty 61.8% 12.3%
SG2D filter penalty 69.6% 26.3%
PIMVq penalty 79.2% 26.6%
FIG. 9. Prostate1 DVHs shown optimized with each of the beam modulation
reduction methods and maximum intensity limits when including mean dose
costlets for the normal tissues equal to the mean doses achieved by the
baseline plan.
Medical Physics, Vol. 34, No. 2, February 2007tested had large primary PTVs and nodal volumes, requiring
large treatment fields that encompassed substantial if not all
volumes of many important normal structures. Consequently,
there was little room to improve plans based upon the addi-
tion of a beam modulation penalty while not interfering with
the high priority dose objectives. Therefore, the MU reduc-
tions observed Fig. 10 for the three head/neck plans were
smaller and plateaued more quickly than those in the pros-
tate. Still, it was possible to reduce modulation and MU with
little loss in plan quality according to the DVHs and dose
metrics. As in the other body sites, target coverage was not
compromised, due to the design of the cost function. Plans
became unacceptable as the modulation penalty grew too
large and, in these cases, the first thing to be violated was
generally the sparing of one parotid or the spinal cord maxi-
mum dose. The PIMVq method penalizes all modulation, no
matter the location; therefore PIMVq penalized plans have
the largest mean spinal cord doses. While a small change
may not be clinically important, larger increases in mean
cord dose, such as those obtained with higher penalty
weights, may warrant a change in the cost function or use of
a smoothing mechanism that would not penalize modulation
near the spinal cord to be reported in a separate publication.
All other mean doses and DVHs are very consistent through-
out the optimization runs, with mean doses varying, in most
cases, by less than 1 Gy. The PIMVq penalty produced the
highest MU reductions, followed by the maximum intensity
limits, SG2D, and SG1D penalties, with the SG1D penalty
producing the most inconsistent MU reductions see Fig. 10.
The highest MU reductions possible while still meeting all of
the high priority objectives are shown in Table IV. As in the
other sites, it was also possible to achieve substantial MU
reductions while maintaining the mean normal tissue doses
achieved in the baseline plan Table IV.
HN2 had additional boost targets within each nodal vol-
ume, making it difficult to meet all of the objectives. Many
plans had difficulties in satisfying the target dose homogene-
ity requirements due to the number of overlapping targets.
Because of this, the limiting factor in the optimization was
not the normal tissue dose. This also explains why the MU
reductions were similar when adding in the mean normal
tissue dose objectives in Table IV. The performance of the
maximum intensity limited plans was poor in this case, dem-
onstrating the need for the higher intensities to reach the
homogeneity goals in the targets. The PIMVq penalty, at
ostate using each optimization technique while i
mean normal tissue doses from the baseline plan.
Prostate2 Prostate3
i only i and ii i only i and ii
62.4% 12.3% 67.6% 12.1%
56.1% 2.2% 51.6% 8.8%
57.2% 16.2% 59.4% 21.9%
71.5% 18.9% 71.7% 26.4%e pr
ining
ihigher weights, successfully reduced MU with almost no
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a 1.7 Gy increase in mean dose to spinal cord at the highest
PIMVq penalty. This plan represented a 52% reduction in
MU as compared to the baseline cost function.
Achieving a mean dose of less than 26 Gy in the left
parotid the only one that could be spared appeared to be the
limiting factor in the optimization in HN3. This case shows
that sometimes limiting the maximum intensity is not desir-
able. Figure 11b shows that higher intensities were neces-
sary in areas near the left parotid the lower right of beam 7,
for example to create gradients in the targets to compensate
for reducing the parotid dose. In the maximum intensity lim-
ited plan, this was not possible and those plans became infe-
rior. The remaining techniques were able to reduce the
modulation while still meeting the plan objectives. The fact
that the smoothing costlets were still utilizable in this com-
plex geometry demonstrates one advantage of including
modulation penalties as weighted costlets versus applying
beamlet restrictions in an absolute sense. The PIMVq penal-
ized plan again had the highest MU reductions, followed by
the SG2D and SG1D filter penalties. The latter techniques
had slightly reduced normal tissue mean doses compared to
the PIMVq penalty, which can be seen in the DVHs in Fig.
11a.
IV. DISCUSSION
A high degree of modulation in intensity modulated radio-
therapy beams can lead to large increases in treatment time
and monitor units as compared to conventional 3DCRT
TABLE IV. Maximum MU reductions possible in th
meeting high priority plan objectives and ii mainta
HN1
Optimization technique i only i and i
Maximum intensity limits 41.8% 26.9%
SG1D filter penalty 28.8% 28.8%
SG2D filter penalty 36.5% 34.0%
PIMVq penalty 47.4% 35.6%
FIG. 10. Plots illustrating relative MU versus net cost tradeoffs in the head/n
cost function and maximum intensity limits. All values are relative to the bMedical Physics, Vol. 34, No. 2, February 2007plans, and planning and quality assurance time. None of
these increases in time and effort is desirable. In this work,
we have investigated several techniques for reducing beam
modulation, with the goal of not significantly altering IMRT
plan quality or the ability of the optimizer to reach the pre-
scribed inverse plan objectives. Each of the modulation pen-
alties studied produced a fairly continuous range of plans and
results at varying weights of the modulation penalty. At
higher weights, there was a greater tradeoff between the low
priority objectives typically overall normal tissue dose mini-
mization and a greater decrease in MU. We have also dem-
onstrated that MU reductions on the order of 13%–52% are
possible in clinical cases with these complexity-reduction
methods, while maintaining the normal tissue mean doses
achieved with a baseline cost function. This provides the user
with a choice of the degree of normal tissue dose increase
acceptable for a certain increase in plan efficiency. Each of
the modulation penalties could be a powerful tool for a do-
simetrist, physicist, or physician to manipulate an IMRT plan
on a case by case basis, depending on the specific goals of
the plan.
Applying maximum intensity limits to beamlet plans is a
simple solution to reduce MU in plans that do not require
high degrees of freedom to meet the plan objectives. Thus,
this method was successful in both the brain and prostate
body sites. However, in the more complicated head/neck
cases, limitations were encountered when certain objectives
were on the border of being violated. In these cases, the
d/neck using each optimization technique while i
mean normal tissue doses from the baseline plan.
HN2 HN3
i only i and ii i only i and ii
40.0% 37.1% 22.6% 18.3%
45.3% 36.2% 31.4% 25.7%
50.8% 50.8% 37.5% 29.5%
52.3% 52.3% 38.5% 33.1%
ases when using each of the modulation penalties compared to the baseline
e plan.e hea
ining
ieck c
aselin
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ability to meet the plan objectives, thus requiring a more
sophisticated smoothing mechanism.
To allow more degrees of freedom in the quest for re-
duced beam complexity, the use of terms in the cost function
to penalize beam modulation were also investigated. The first
penalty was based on a 1-D Savitzky-Golay filter SG1D
penalty applied only in the direction of the MLC travel,
while the second penalty was based on a 2-D filter SG2D
penalty. The third modulation costlet penalized the sum of
squared differences between all neighboring beamlets
PIMVq penalty. Each of these penalties, when applied with
a reasonable weight in a weighted sum cost function, suc-
cessfully reduced plan modulation, while still allowing the
optimizer ample freedom to meet the plan objectives. An
advantage of using these penalties inside the cost function is
that tradeoffs with normal structure doses are controlled by
the weight of the modulation penalty. This would be impos-
sible if a smoothing procedure were applied iteratively or
postoptimization. The SG1D penalty has been used previ-
ously and shown to be effective compared to applying
smoothing operations after each optimization iteration.7 We
have observed that while this method can effectively reduce
modulation and MU in most cases, its behavior can be some-
what unpredictable at increased weights of the penalty. Also,
it i only decreases modulation in one direction, creating a
steplike intensity pattern in the direction perpendicular to
leaf travel, which is entirely nonintuitive when compared to
patient anatomy, ii could introduce unwanted errors in QA
and delivery, and iii could potentially increase a plan’s sen-
sitivity to geometric shifts in the direction perpendicular to
MLC travel. However, these potentially negative features
were useful in cases where smaller structures were present in
the field such as the penile bulb in the prostate and the
spinal cord in the head/neck. Still, in the majority of the
cases studied here, using the SG2D penalty was superior in
terms of overall beam modulation reduction and MU reduc-
tion, while producing plans with similar DVHs and dose
Medical Physics, Vol. 34, No. 2, February 2007metrics. We believe that in most cases, a 2-D modulation
penalty should be applied to reduce potential problems with
QA and delivery.
Finally, the PIMVq penalty most consistently reduced MU
as the weight was increased. This method eliminates the need
for a separate computation of the smoothed filtered beam, as
it simply penalizes a direct measure of the overall beam
modulation. The behavior of this penalty was very predict-
able for every plan studied. A potential problem in this
method is that it penalizes all modulation, whereas the SG
penalties only penalize deviation from a smoothed version of
the plan. In the head/neck plans, where the spinal cord fre-
quently lies in the beam, the beam gradient is reduced as a
result of the penalty, and the mean dose to the spinal cord is
increased. In cases such as this, the Savitzky-Golay methods
may be best suited, or changes to the cost function may need
to be made when using the PIMV-based penalty. Also, it may
be advantageous to examine the use of “smarter” smoothing
mechanisms that can distinguish between areas that should
or should not be smoothed. Such a method has been investi-
gated by Llacer et al., who showed that for a simple 2-D test
case, a space-variant filter can be more effective at smooth-
ing without compromising PTV coverage than other conven-
tional filtering techniques.8 We are currently investigating
another method based on diffusion principles for 3-D inverse
planning that will allow for preferential smoothing based on
any desired parameter, such as the beam intensity, gradient,
or proximity to organ at risk; these results will be reported
separately.26
As mentioned previously, a competing method for im-
proving plan delivery accuracy and efficiency is the optimi-
zation of the size and shape of the segments to be used in
IMRT delivery. We are currently working on a fair compari-
son of an in-house developed algorithm, called direct seg-
ment optimization DSO,27,28 to fluence map optimization
FIG. 11. a HN3 DVHs shown opti-
mized with each of the beam modu-
lation reduction techniques and b
corresponding HN3 beams optimized
with each of the beam modulation re-
duction methods. SMLC reductions
are in parentheses.with smoothing and improved leaf sequencing, to determine
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cases while aiming to improve overall planning and delivery
efficiency.
It is of interest to note that several authors have reported
an increase in planning efficiency when incorporating
smoothing into the cost function in contrast to smoothing at
each iteration.7,29 We have also observed this trend and agree
that this is most likely due to an increase in curvature of the
cost function near the global minimum, reducing the time to
fine-tune the plan after convergence.
Another potential advantage to reducing beam complexity
is a decrease in delivery time. In fact, we observed delivery
time reductions on the order of 25% in the prostate cases
studied here, but did not see a significant reduction in deliv-
ery time in the other body sites. It may be that the effective
leaf travel is not substantially reduced until the beam is al-
most flat. However, more analysis needs to be done on the
delivery time implications of these methods.
One disadvantage of incorporating smoothing into the
cost function is a difficulty in analyzing the tradeoffs be-
tween the smoothness criteria and the target and normal tis-
sue objectives. However, this problem remains for assessing
all weighted-sum cost function plans, and the proposed
Pareto surface navigation could be applied to analyze the
tradeoffs in question.30 We are also investigating the use of a
modulation penalty as a priority stage in a Lexicographic
ordering optimization.31 Depending on the available solution
space, this method could eliminate the need to assess the
tradeoffs with the smoothing penalty and other planning ob-
jectives. Nevertheless, it currently remains a case-by-case
situation to properly incorporate smoothing into a cost func-
tion, and this general approach would most likely include
iterating through several importance factors for smoothness
before reaching the desired solution. The resulting trial and
error process may offset the decreased time needed for opti-
mization, but the ultimate increase in plan quality based
upon improved QA and delivery efficiency should prove
beneficial.
V. CONCLUSIONS
Three different modulation penalties were applied in the
inverse planning cost function to reduce the complexity of
IMRT beams. After validation in a CT phantom, the penalties
were tested in the brain, prostate, and head/neck. Application
of each of the penalties in a weighted sum cost function
produced plans that met prescribed planning objectives with
large decreases in monitor units required for delivery. The
large decreases in plan modulation not only improve delivery
efficiency, but potentially decrease planning and quality as-
surance time or difficulty. We believe that each of these
methods has merit for improving IMRT plan quality and
could be used as a cost function component on a regular
basis for the purpose of reducing unnecessary beam modula-
tion. For the greatest benefit in MU reduction, we recom-
mend the use of a 2-D modulation penalty and have found
that the plan intensity map variation penalty is best suited for
the majority of cases, as it produced the greatest reduction in
Medical Physics, Vol. 34, No. 2, February 2007monitor units with the least amount of computation needed.
However, the Savitzky-Golay 2-D filter penalty may be bet-
ter at preserving a certain degree of modulation for cases in
which critical normal structures lie within the bounds of the
beams. We expect that the inclusion of these various tools
will continue to refine and improve the application and plan-
ning of intensity modulated radiation therapy treatments.
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